AMSBIO Unveils New Range of Cytokines Tailored for Organoid and Stem Cell Studies
AMS Biotechnology (Amsbio) has introduced a new range of over 30 independently developed and manufactured organoid culture-related cytokines for researchers working with stem cells and induced pluripotent stem cells (iPSCs).
AMS Biotechnology (Amsbio) | 14/10/2025 | By Dineshwori
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy